Company intelligence / Profile preview

Hefei Lifeon Pharmaceutical

Hefei, Anhui, Chinalifeonapi.com ↗
Ownership
Private
Employees
~1315
Development stage
Other
01

Overview

Hefei Lifeon Pharmaceutical has a broad commercial portfolio including APIs and finished dosage forms for CNS, cardiovascular, digestive system diseases, ophthalmology and more. It is the largest osmotic pump preparation producer in China. Several products are FDA-inspected with zero defects. The company has ongoing clinical programs through affiliates/subsidiaries.

Therapeutic areas
OncologyPulmonologyHematologyDermatologyGastroenterologyCardiovascularOphthalmologyNeurology
Modalities
Small moleculeHerbal medicineChemical drugsTraditional Chinese medicine extract
Industry
Biotech
02

Drug pipeline

4 assets

uroacitides

4

3 more assets in the full pipeline.

Beyond the preview

Go deeper on Hefei Lifeon Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei Lifeon Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call